Processing, please wait...
10 videos

Dr Sami SALAHIA

MD
Egypt

Dr. Sam Salahia, MBBCh is a medical doctor who graduated from the faculty of medicine, Ain Shams University, and finished his Internship as a House Officer at Ain Shams University Hospital in Cairo, Egypt. He is interested to start his journey in cosmetic dermatology, laser, and dermatologic surgery fields and being able to have an experience in recent techniques to treat dermatological cases and discover methods in anti-aging and regenerative medicine using medical research. He has an experience in medical research since 2015 as he published different research studies in different specialties using primary and secondary research in addition to his participation in international medical conferences across the world.

read more
add item add Sami SALAHIA

Sami SALAHIA's publications (6)

Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.

Jan, 2019

Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for better clinical practice guidelines. We aimed to describe the TCC incidence and incidence-based mortality by demographic and tumor-related characteristics over the last 40 years in the US. read more

BMC cancer

Chilaiditi syndrome - a rare case of pneumoperitoneum in the emergency department: a case report.

Sep, 2018

Pneumoperitoneum poses an important diagnostic sign determining the urgency of management of patients in an emergency department. Chilaiditi sign is a rare radiologic finding of large intestines transposition between the diaphragm and the liver. If the patient becomes symptomatic, then the condition is called Chilaiditi syndrome. read more

Journal of medical case reports

Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.

Apr, 2018

Usually, clinical trials on esophageal cancer exclude patients with a prior malignancy, assuming that this may influence survival outcomes. However, little is known about the impact of a prior malignancy on its prognosis. read more

Expert review of gastroenterology & hepatology
Load more